The current valuation score of MDxHealth SA is 9.03, ranking 61 out of 384 in the Biotechnology & Medical Research industry. Its current P/E ratio is -0.63, which is -1.88% below the recent high of -0.61 and -951.42% above the recent low of -6.59.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.